Achneck Hardean
SEC insider (Form 3/4/5 filer). CIK 0002037976. Chief Medical Officer at Aligos Therapeutics, Inc. (ALGS). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 8, 2024. Located in SOUTH SAN FRANCISCO, CA.
Companies Achneck Hardean has filed insider reports for
- Aligos Therapeutics, Inc. (ALGS): Officer, Chief Medical Officer
Achneck Hardean
CIK: 0002037976
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALGS
Aligos Therapeutics, Inc.
Officer